Wall Street
Price Targets

SGT Price Targets Summary
Seagen Inc

There are no price targets for SGT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Seagen Inc Competitors:
Price Targets
4BB
4Basebio PLC
182% Upside
FHTX
Foghorn Therapeutics Inc.
110% Upside
688278
Xiamen Amoytop Biotech Co Ltd
24% Upside
GBIO
Generation Bio Co
62% Upside
CELC
Celcuity Inc
10% Upside
ARMP
Armata Pharmaceuticals Inc
43% Upside
ARQT
Arcutis Biotherapeutics Inc
10% Upside
145020
Hugel Inc
57% Upside

Revenue
Forecast

Revenue Estimate
Seagen Inc

For the last 8 years the compound annual growth rate for Seagen Inc's revenue is 27%. The projected CAGR for the next 4 years is 28%.

27%
Past Growth
28%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Seagen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Seagen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SGT's stock price target?
Not Available

SGT doesn't have any price targets made by Wall Street professionals.

What is Seagen Inc's Revenue forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Seagen Inc's revenue is 27%. The projected CAGR for the next 4 years is 28%.

Back to Top